Simplify your online presence. Elevate your brand.

Legislative Regulatory Covermymeds

Legislative Regulatory Covermymeds
Legislative Regulatory Covermymeds

Legislative Regulatory Covermymeds In this digital version of the 2021 medication access report: legislative and regulatory edition, we spoke with legislators and lobbyists helping shape policies to improve medication access, affordability and adherence. Covermymeds is accelerating specialty patient access with unified pa workflows, intelligent automation and an ehr‑connected platform built for oncology, ophthalmology and beyond.

Legislative Regulatory Covermymeds
Legislative Regulatory Covermymeds

Legislative Regulatory Covermymeds Conclusion despite efforts in congress to repeal and replace the ppaca, no legislative changes have been enacted. the focus now turns to administrative branch (regulatory) action for commercial and public sector insurance. Tracy russell, senior director, state government affairs at covermymeds, discusses state and federal legislation that may be impacting the future of specialty pharmacies and the patient care they deliver. Much like their federal counterparts, state legislative and regulatory bodies will continue to hold covid 19 related issues as a top priority moving into 2021 while also addressing budget deficits and healthcare access concerns. There are several pieces of legislation that could have an impact on drug rebates, explained tracy russell, senior director, government affairs, covermymeds.

Legislative Regulatory Covermymeds
Legislative Regulatory Covermymeds

Legislative Regulatory Covermymeds Much like their federal counterparts, state legislative and regulatory bodies will continue to hold covid 19 related issues as a top priority moving into 2021 while also addressing budget deficits and healthcare access concerns. There are several pieces of legislation that could have an impact on drug rebates, explained tracy russell, senior director, government affairs, covermymeds. Covermymeds is compliant with all epa legislation. in addition to states that require epa today, many have pending legislation, making it a good idea for providers and their staff to begin using an electronic submission method. In response, states have begun to enact legislation addressing pbms, with all 50 states having enacted at least one pbm related law between 2017 and 2023. gao was asked to review states’ regulation of pbms serving private health plans. Physicians and pharmacies are facing heightened audit enforcement and fraud, waste & abuse (fwa) investigations by express scripts, inc. (esi), relating to prior authorizations. The push for increased oversight will likely continue in 2024 with possible legislative and regulatory changes to data collection and publication, prior authorization, and supplemental benefit policies.

Legislative Regulatory Covermymeds
Legislative Regulatory Covermymeds

Legislative Regulatory Covermymeds Covermymeds is compliant with all epa legislation. in addition to states that require epa today, many have pending legislation, making it a good idea for providers and their staff to begin using an electronic submission method. In response, states have begun to enact legislation addressing pbms, with all 50 states having enacted at least one pbm related law between 2017 and 2023. gao was asked to review states’ regulation of pbms serving private health plans. Physicians and pharmacies are facing heightened audit enforcement and fraud, waste & abuse (fwa) investigations by express scripts, inc. (esi), relating to prior authorizations. The push for increased oversight will likely continue in 2024 with possible legislative and regulatory changes to data collection and publication, prior authorization, and supplemental benefit policies.

Legislative Regulatory Covermymeds
Legislative Regulatory Covermymeds

Legislative Regulatory Covermymeds Physicians and pharmacies are facing heightened audit enforcement and fraud, waste & abuse (fwa) investigations by express scripts, inc. (esi), relating to prior authorizations. The push for increased oversight will likely continue in 2024 with possible legislative and regulatory changes to data collection and publication, prior authorization, and supplemental benefit policies.

Comments are closed.